Back
Alnylam Pharmaceuticals Vs. Charles River Laboratories International Industry Stock Comparison
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
$267.17
Seasonality Move:
25.91%
Buy
59
CRL
Charles River Laboratories International
Last Price:
$144.07
Seasonality Move:
7.09%
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $270.19. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
-
The current Charles River Laboratories International [CRL] share price is $143.08. The Score for CRL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $270.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $143.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight selling pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.74 | Buy |
| Relative Strength Index (14 RSI): | 57.03 | Buy |
| Chaikin Money Flow: | 1250602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (232.65 - 263.01) | Buy |
| Bollinger Bands (100): | (237.39 - 268.51) | Buy |
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.93 | Buy |
| Relative Strength Index (14 RSI): | 62.18 | Buy |
| Chaikin Money Flow: | -450378 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.66 - 131.32) | Buy |
| Bollinger Bands (100): | (130.85 - 182.43) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.27 | Buy |
| 20-day SMA: | 251.55 | Buy |
| 50-day SMA: | 251.88 | Buy |
| 200-day SMA: | 259.25 | Buy |
| 8-day EMA: | 262.44 | Buy |
| 20-day EMA: | 256.68 | Buy |
| 50-day EMA: | 253.87 | Buy |
| 200-day EMA: | 246.01 | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 128.8 | Buy |
| 20-day SMA: | 117.66 | Buy |
| 50-day SMA: | 140.26 | Buy |
| 200-day SMA: | 178.62 | Sell |
| 8-day EMA: | 131.69 | Buy |
| 20-day EMA: | 122.29 | Buy |
| 50-day EMA: | 97.4 | Buy |
| 200-day EMA: | 39.8 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.58 per share, and an increase next year of $0.66 per share.
Alnylam Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Charles River Laboratories International Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||